Login / Signup

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

Matthew J CrowleyDarren K McGuireAnastasia-Stefania AlexopoulosThomas Jon JensenSøren RasmussenHans A SaevereidSubodh VermaJohn B Buse
Published in: Diabetes care (2020)
Keyphrases
  • type diabetes
  • phase iii
  • study protocol
  • phase ii
  • glycemic control
  • clinical trial
  • cardiovascular disease
  • insulin resistance
  • open label
  • metabolic syndrome